Thomas H. Tulip
2012
In 2012, Thomas H. Tulip earned a total compensation of $713.4K as President and Chief Business Officer at Navidea Biopharmaceuticals, a 27% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $75,075 |
|---|---|
| Option Awards | $314,151 |
| Salary | $314,583 |
| Other | $9,615 |
| Total | $713,424 |
Tulip received $314.6K in salary, accounting for 44% of the total pay in 2012.
Tulip also received $75.1K in non-equity incentive plan, $314.2K in option awards and $9.6K in other compensation.
Rankings
In 2012, Thomas H. Tulip's compensation ranked 7,490th out of 11,487 executives tracked by ExecPay. In other words, Tulip earned more than 34.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,490 out of 11,487 | 35th |
Division Manufacturing | 2,693 out of 4,253 | 37th |
Major group Chemicals And Allied Products | 696 out of 1,203 | 42nd |
Industry group Drugs | 485 out of 925 | 48th |
Industry In Vitro and In Vivo Diagnostic Substances | 22 out of 47 | 53rd |
Source: SEC filing on June 5, 2015.
Tulip's colleagues
We found four more compensation records of executives who worked with Thomas H. Tulip at Navidea Biopharmaceuticals in 2012.
2012
Mark Pykett
Navidea Biopharmaceuticals
Chief Executive Officer
2012
Frederick Cope
Navidea Biopharmaceuticals
Chief Scientific Officer
2012
Brent Larson
Navidea Biopharmaceuticals
Chief Financial Officer
2012
Rodger Brown
Navidea Biopharmaceuticals